Latest publication: Melzer D, Hogarth S, Liddell K, Ling T, Sanderson S, Zimmern RL. Genetic tests for common diseases: new insights, old concerns. BMJ 2008 Mar 15;336(7644):590-3
Go to article summary on BMJ website
Full text**
Burke W, Zimmern R and Kroese M. Defining purpose: a key step in genetic test evaluation. Genetics in Medicine 2007 9(10):675-681.
Click here for full text pdf. (courtesy of Lippincott, Williams and Wilkins publishers)
Khoury MJ, Gwinn M, Burke W, Bowen S, Zimmern R. Will genomics widen or help heal the schism between medicine and public health? Am J Prev Med. 2007 Oct;33(4):310-17.
Go to Entrez PubMed reference (full text access requires subscription to journal)
Kroese M, Zimmern RL, Pinder SE. HER2 status in breast cancer - an example of pharmacogenetic testing. J R Soc Med. 2007 Jul;100(7):326-9.
Go to Entrez PubMed reference (full text access requires subscription to journal)
Zimmern RL, Kroese M. The evaluation of genetic tests. J Public Health (Oxf). 2007 May 24; [Epub ahead of print]
Go to PubMed abstract
Bennett C, Burton H, Farndon P. (2007) Competences, education and support for new roles in cancer genetics services: outcomes from the cancer genetics pilot projects. Fam Cancer. 6(2):171-80.
Ioannidis JPA, Gwinn ML, Little J, Higgins JPT, Zimmern R, et al. A roadmap for developing an efficient and credible human genome epidemiology. Nature Genetics 2006;38(1):3-5.
Sanderson S. Joint effects of NAT1, NAT2 genes and smoking on bladder carcinogenesis: a HuGE literature-based systematic review and evidence synthesis (In Press). Am.J.Epidemiol. 2006.
Sanderson S, Green A, Preece M, Burton H. The frequency of inherited metabolic disorders in the West Midlands, United Kingdom. (In press) Archives of Disease in Childhood 2006.
Burton H, Sanderson S, Shortland G, Lee P. Needs assessment and review of services for people with inherited metabolic disease in the United Kingdom (In Press). Journal of Inherited Metabolic Disease 2006.
Subramonia-Iyer S, Sagoo G, Sanderson S, Higgins JP, Burton H, Brice P et al. Array-based comparative genomic hybridisation for investigating chromosomal abnormalities in patients with learning disability: meta-analysis of diagnostic and false positive yields. (In press) Genet Med. 2006.
Burton H, Zimmern R. Education in the genetics era: genetics education for health professionals - an essential component of genetics policy. Medical Education 2005;39(3):243-4.
Corrigan OP. Pharmacogenetics, ethical issues: review of the Nuffield Council on Bioethics Report. J Med.Ethics 2005;31(3):144-8.
Dutta I, Brice PC, Wallace S. Knowledge sharing and 'genomic' healthcare. Nat.Biotechnol. 2005;23(2):169-70.
Liddell K, Hall A. Beyond Bristol and Alder Hey: The Future Regulation of Human Tissue. Medical Law Review 2005;Summer:170-223.
Liddell K, Wallace S. Emerging Regulatory Issues for Human Stem Cell Medicine. Genomics, Society and Policy 2005;1(1):54-73.
Melzer D, Raven A, Ling T, Detmer D, Zimmern R. Pharmacogenetics: policy needs for personal prescribing. Journal of Health Services Research and Policy 2005;10(1):40-4.
Sanderson S, Emery J, Higgins J. CYP2C9 gene variants, drug dose, and bleeding risk in warfarin-treated patients: A HuGEnet trade mark systematic review and meta-analysis. Genet Med. 2005;7(2):97-104.
Sanderson S, Zimmern R, Kroese M, Higgins J, Patch C, Emery J. How can the evaluation of genetic tests be enhanced? Lessons learned from the ACCE framework and evaluating genetic tests in the United Kingdom. Genetics in Medicine 2005;7(7):495-500.
Burke W, Zimmern R, . Ensuring the appropriate use of genetic tests. Nat.Rev.Genet 2004;5(12):955-8.
Kroese M, Zimmern R, Sanderson S. Genetic tests and their evaluation: Can we answer the key questions? Genetics in Medicine 2004;6(6):475-80.
Liddell K, Menon DK, Zimmern R. The Human Tissue Bill and the Mental Capacity Bill. British Medical Journal (BMJ) 2004;328(7455):1510-1.
Morgan M, Wallace S. The international human genome project: an overview. In: Brannigan MC, editor. Cross-cultural biotechnology. A reader. 2004 ed. Oxford: Rowman and Littlefield; p. 265-75.
Tutton R, Corrigan OP. Genetic Databases: Social-ethical issues in the collection and use of DNA. 2004 ed. London: Routledge
Burton H, Shuttleworth A. Genetics education for primary health care nurses. Primary Health Care 2003;13(4):35-8.
Burton H, Watson L, Brice P. The NHS in the era of genetics: implications for community practitioners. Community Practitioner 2003;76(8):288-90.
Burton H, Shuttleworth A, Metcalfe A. Genetics education for nurses, midwives and health visitors. Prof.Nurse 2003;18(12):676-80.
Burton H, Shuttleworth A. Genetics education for pharmacists. The Pharmaceutical Journal 2003;270(7232):84-5.
Burton H, Stewart A. From Mendel to the Human Genome Project: the implications for nurse education. Nurse Educ Today 2003;23(5):380-5.
Burton H, Shuttleworth A. Genetics education for midwives. RCM.Midwives.J 2003;6(4):162-4.
Corrigan OP, Williams-Jones B. Pharmacogenetics: The bioethical problem of DNA investment banking. Stud Hist Phil Biol & Biomed Sci 2003;In press.
Corrigan OP. Empty ethics: the problem with informed consent. Sociology of Health & Illness 2003;25(3):768-92.
Liddell K. Purposive interpretation and the march of genetic technology. Case comment on the R v HFEA 2 W.L.R. (cell nuclear transfer case). Cambridge Law Journal 2003;62(3):563-6.
McMillan J, Hope T. Gametes, money, and egg sharing. Lancet 2003;362(9383):584.
Melzer D, Zimmern RL, Detmer DE, Ling T. Regulatory options for pharmacogenetics. Pharmacogenomics 2003;4(5):527-30.
Melzer D, Detmer D, Zimmern R. Pharmacogenetics and public policy: expert views in Europe and North America. Pharmacogenomics 2003;4(6):689-91.
Metcalfe A, Burton H. Postregistration genetics education provision for nurses, midwives and health visitors. Journal of Adv Nursing 2003;44(4):350-9.
Stewart A, Zimmern R. (Almost) three cheers for UK genetics White Paper. Lancet 2003;362(9381):341-2.
Williams-Jones B, Corrigan OP. Rhetoric and hype: Where's the "ethics" in pharmacogenomics? American Journal of Pharmacogenomics 2003;3(6):375-83.
Austin MA, Zimmern RL, Humphries SE. High "population attributable fraction" for coronary heart disease mortality among relatives in monogenic familial hypercholesterolemia. Genetics in Medicine 2002;4(4):275-8.
Burke W, Emery J. Science and society: Genetics education for primary-care providers. Nat.Rev.Genet 2002;3(7):561-6.
Melzer D, Zimmern R. Genetics and medicalisation. BMJ 2002;324(7342):863-4.
Pharoah PD, Antoniou A, Bobrow M, Zimmern RL, Easton DF, Ponder BA. Polygenic susceptibility to breast cancer and implications for prevention. Nat.Genet. 2002;31(1):33-6.